Le Lézard
Classified in: Health
Subjects: NPT, AVO

ENA-Supported Workplace Violence Bill Passed by House of Representatives


SCHAUMBURG, Ill., Nov. 21, 2019 /PRNewswire/ -- The U.S. House of Representatives on Thursday made a definitive statement of support for the safety of health care workers when it voted to approve The Workplace Violence Prevention for Health Care and Social Services Act of 2019 ? a bill strongly backed by the Emergency Nurses Association.

(PRNewsfoto/Emergency Nurses Association)

The epidemic of workplace attacks on emergency nurses, and health care workers in general, is borne out in statistics from the Occupational Safety and Health Administration that show 50 percent of workplace assault victims are employed in the health care sector. OSHA further noted that between 2002-13, serious workplace violence incidents were four times more likely to occur to a health care worker compared to all other workers in the United States.

H.R. 1309, which passed by a 251-158 vote, ensures that health care and social service employers, including hospitals, take specific steps to prevent workplace violence and ensure the safety of patients and workers. This legislation directs the Secretary of Labor, through OSHA, to require these employers to develop and implement workplace violence prevention plans that are worker driven and comprehensive.

"House passage of the workplace violence prevention act is a major victory for emergency nurses and all health care providers. Today's vote puts us all one step closer to a safer work environment and, ultimately, peace of mind that we can care for our patients knowing that our facility has taken the proper measures to protect us," said ENA President Patti Kunz Howard, PhD, RN, CEN, CPEN, TCRN, NE-BC, FAEN, FAAN.

ENA praised the work of Rep. Joe Courtney, D-Conn., who introduced H.R. 1309 earlier this year. The bill now moves to the Senate for consideration.

ENA has long been a vocal supporter of legislation focused on curbing the epidemic of workplace violence in health care, and particularly in the emergency department. In May during its annual Day on the Hill event, nearly 175 ENA members spoke to the issue during meetings with members of Congress and their staffers.

Just this week, ENA and the American College of Emergency Physicians launched the "No Silence on ED Violence" campaign ? a collaborative effort that aims to support, empower and protect those working in our nation's emergency departments by raising awareness of the serious dangers emergency health providers face every day, and by generating action among stakeholders and policymakers to ensure a violence-free workplace for emergency nurses and physicians.

About the Emergency Nurses Association
The Emergency Nurses Association is the premier professional nursing association dedicated to defining the future of emergency nursing through advocacy, education, research, innovation, and leadership. Founded in 1970, ENA has proven to be an indispensable resource to the global emergency nursing community. With more than 44,000 members worldwide, ENA advocates for patient safety, develops industry-leading practice standards and guidelines, and guides emergency healthcare public policy. ENA members have expertise in triage, patient care, disaster preparedness, and all aspects of emergency care. Additional information is available at www.ena.org.

ENA Media Contact:
Dan Campana
Senior Manager, Communications
847-460-4017
[email protected]

SOURCE Emergency Nurses Association


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: